vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Safehold Inc. (SAFE). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $97.9M, roughly 1.7× Safehold Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 6.5%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 2.5%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
SAFE Investment Company Limited is a Chinese sovereign wealth fund based in Hong Kong.
ESPR vs SAFE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $97.9M |
| Net Profit | — | $27.9M |
| Gross Margin | — | 98.6% |
| Operating Margin | 50.6% | 27.4% |
| Net Margin | — | 28.5% |
| Revenue YoY | 143.7% | 6.5% |
| Net Profit YoY | — | 7.1% |
| EPS (diluted) | $0.32 | $0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $97.9M | ||
| Q3 25 | $87.3M | $96.2M | ||
| Q2 25 | $82.4M | $93.8M | ||
| Q1 25 | $65.0M | $97.7M | ||
| Q4 24 | $69.1M | $91.9M | ||
| Q3 24 | $51.6M | $90.7M | ||
| Q2 24 | $73.8M | $89.9M | ||
| Q1 24 | $137.7M | $93.2M |
| Q4 25 | — | $27.9M | ||
| Q3 25 | $-31.3M | $29.3M | ||
| Q2 25 | $-12.7M | $27.9M | ||
| Q1 25 | $-40.5M | $29.4M | ||
| Q4 24 | — | $26.0M | ||
| Q3 24 | $-29.5M | $19.3M | ||
| Q2 24 | $-61.9M | $29.7M | ||
| Q1 24 | $61.0M | $30.7M |
| Q4 25 | — | 98.6% | ||
| Q3 25 | — | 98.5% | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | — | 98.8% | ||
| Q4 24 | — | 98.8% | ||
| Q3 24 | — | 98.8% | ||
| Q2 24 | — | 98.8% | ||
| Q1 24 | — | 98.8% |
| Q4 25 | 50.6% | 27.4% | ||
| Q3 25 | -11.4% | 25.9% | ||
| Q2 25 | 8.6% | 25.5% | ||
| Q1 25 | -34.0% | 25.9% | ||
| Q4 24 | -6.4% | 24.6% | ||
| Q3 24 | -31.0% | 17.5% | ||
| Q2 24 | 3.5% | 26.7% | ||
| Q1 24 | 52.5% | 26.4% |
| Q4 25 | — | 28.5% | ||
| Q3 25 | -35.9% | 30.5% | ||
| Q2 25 | -15.4% | 29.8% | ||
| Q1 25 | -62.2% | 30.1% | ||
| Q4 24 | — | 28.3% | ||
| Q3 24 | -57.2% | 21.3% | ||
| Q2 24 | -83.9% | 33.0% | ||
| Q1 24 | 44.3% | 33.0% |
| Q4 25 | $0.32 | $0.38 | ||
| Q3 25 | $-0.16 | $0.41 | ||
| Q2 25 | $-0.06 | $0.39 | ||
| Q1 25 | $-0.21 | $0.41 | ||
| Q4 24 | $-0.14 | $0.36 | ||
| Q3 24 | $-0.15 | $0.27 | ||
| Q2 24 | $-0.33 | $0.42 | ||
| Q1 24 | $0.34 | $0.43 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $21.7M |
| Total DebtLower is stronger | — | $4.6B |
| Stockholders' EquityBook value | $-302.0M | $2.4B |
| Total Assets | $465.9M | $7.2B |
| Debt / EquityLower = less leverage | — | 1.90× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $21.7M | ||
| Q3 25 | $92.4M | $12.1M | ||
| Q2 25 | $86.1M | $13.9M | ||
| Q1 25 | $114.6M | $17.3M | ||
| Q4 24 | $144.8M | $8.3M | ||
| Q3 24 | $144.7M | $15.6M | ||
| Q2 24 | $189.3M | $13.4M | ||
| Q1 24 | $226.6M | $11.3M |
| Q4 25 | — | $4.6B | ||
| Q3 25 | — | $4.5B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.2B | ||
| Q1 24 | — | $4.1B |
| Q4 25 | $-302.0M | $2.4B | ||
| Q3 25 | $-451.4M | $2.4B | ||
| Q2 25 | $-433.5M | $2.4B | ||
| Q1 25 | $-426.2M | $2.4B | ||
| Q4 24 | $-388.7M | $2.3B | ||
| Q3 24 | $-370.2M | $2.3B | ||
| Q2 24 | $-344.2M | $2.3B | ||
| Q1 24 | $-294.3M | $2.3B |
| Q4 25 | $465.9M | $7.2B | ||
| Q3 25 | $364.0M | $7.1B | ||
| Q2 25 | $347.1M | $7.1B | ||
| Q1 25 | $324.0M | $6.9B | ||
| Q4 24 | $343.8M | $6.9B | ||
| Q3 24 | $314.1M | $6.8B | ||
| Q2 24 | $352.3M | $6.8B | ||
| Q1 24 | $373.1M | $6.7B |
| Q4 25 | — | 1.90× | ||
| Q3 25 | — | 1.89× | ||
| Q2 25 | — | 1.87× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.88× | ||
| Q2 24 | — | 1.81× | ||
| Q1 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $47.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $47.8M | ||
| Q3 25 | $-4.3M | $-1.4M | ||
| Q2 25 | $-31.4M | $28.0M | ||
| Q1 25 | $-22.6M | $8.9M | ||
| Q4 24 | $-35.0M | $37.9M | ||
| Q3 24 | $-35.3M | $8.3M | ||
| Q2 24 | $-7.2M | $24.8M | ||
| Q1 24 | $53.8M | $-3.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | -0.05× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | 0.88× | -0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SAFE
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $60.3M | 62% |
| Other | $33.7M | 34% |
| Stabilized Properties | $3.8M | 4% |
